New therapeutics for osteoporosis

KW Ng, TJ Martin - Current opinion in pharmacology, 2014 - Elsevier
Highlights•Selective cathepsin K inhibition inhibits bone resorption in clinical and preclinical
studies.•Wnt signaling promotes bone formation.•Blockade of Wnt inhibitors increases bone …
被引用次数：29 相关文章

New therapeutics for osteoporosis

KW Ng, TJ Martin - Current Opinion in Pharmacology, 2014 - infona.pl
Two new approaches for the treatment of osteoporosis are summarized, each having arisen
out of important new discoveries in bone biology. Odanacatib (ODN) inhibits the enzyme …

[引用][C] New therapeutics for osteoporosis

KW Ng, TJ Martin - Current Opinion in Pharmacology, 2014 - cir.nii.ac.jp

New therapeutics for osteoporosis

KW Ng, TJ Martin - Current opinion in pharmacology, 2014 - pubmed.ncbi.nlm.nih.gov
Two new approaches for the treatment of osteoporosis are summarized, each having arisen
out of important new discoveries in bone biology. Odanacatib (ODN) inhibits the enzyme …

New therapeutics for osteoporosis.

KW Ng, TJ Martin - Current Opinion in Pharmacology, 2014 - europepmc.org
Two new approaches for the treatment of osteoporosis are summarized, each having arisen
out of important new discoveries in bone biology. Odanacatib (ODN) inhibits the enzyme …